Odyssean »

Nexpoint Credit Strategies Fund shares owned by Odyssean

Quarter-by-quarter ownership of Nexpoint Credit Strategies Fund (NXDT) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Nexpoint Credit Strategies Fund

Tip: Access up to 7 years of quarterly data

All positions including Nexpoint Credit Strategies Fund held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nexpoint Credit Strategies Fund by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $492k 95k 5.19

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Nexpoint Credit Strategies Fund

Highland Capital Management Fund Advisors
Raymond James Financial
BlackRock
Morgan Stanley
Vanguard Capital Management
Geode Capital Management
Deschutes Portfolio Strategy
TCW Group
State Street Corporation
Cambridge Investment Research Advisors
Charles Schwab Investment Management
Oppenheimer & Co
Concorde Asset Management
Northern Trust
Brooklyn Capital Management

View all funds holding Nexpoint Credit Strategies Fund